Structural requirements for conserved arginine of parathyroid hormone

被引:10
作者
Barbier, JR [1 ]
MacLean, S [1 ]
Whitfield, JF [1 ]
Morley, P [1 ]
Willick, GE [1 ]
机构
[1] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada
关键词
D O I
10.1021/bi010460k
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Arg-20 is one of two residues conserved in all peptides known to activate the parathyroid hormone (PTH) receptor. Previous studies have failed to find any naturally encoded analogues of residue 20 that had any adenylyl cyclase (AC) stimulating activity. In this work we have studied substitutions of Arg-20 with nonencoded amino acids and conformationally constrained analogues with side chains mimicking that of Arg. No analogue had more than 20% of the AC-stimulating ability of the natural Arg-20-bearing peptide. In descending order of activity, the most active analogues had (S)-4-piperidyl(N-amidino)glycine (PipGly), norleucine (Nle), citrulline (Cit), or ornithine (Orm) at residue 20. Analogues with Arg-20 substituted with L-4-piperidyl-(N-amidino)alanine, Lys, Glu, Ala, Gln, (S)-2-amino-4-[(2-amino)pyrimidinyl]butanoic acid, or L-(4-guanidino)phenylalanine had very low or negligible activity. Low or negligible activities of Lys or Orn analogues suggested ionic interactions play a minor role in the Arg interaction with the receptor. The conformational constraints imposed by the PipGly ring had a negative effect on its ability to substitute for Arg. The side-chain H-bonding potential of the Cit ureimido group was likely an important factor in its mimicry of Arg. The increase in amphiphilicity, as demonstrated by its greater high-performance liquid chromatographic retention, and increased alpha -helix. as shown by circular dichroic spectroscopy, likely contributed to the activity of the Nle-20 analogue. The data demonstrated that specific H-bonding, hydrophobicity of the side chain, stabilization of alpha -helix, and possibly specific cation positioning were all important in the interaction of Arg-20 with receptor groups.
引用
收藏
页码:8955 / 8961
页数:7
相关论文
共 42 条
[1]   Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures [J].
Andreassen, TT ;
Ejersted, C ;
Oxlund, H .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (06) :960-968
[2]   Structure and activities of constrained analogues of human parathyroid hormone and parathyroid hormone-related peptide: Implications for receptor-activating conformations of the hormones [J].
Barbier, JR ;
MacLean, S ;
Morley, P ;
Whitfield, JF ;
Willick, GE .
BIOCHEMISTRY, 2000, 39 (47) :14522-14530
[3]   Bioactivities and secondary structures of constrained analogues of human parathyroid hormone: Cyclic lactams of the receptor binding region [J].
Barbier, JR ;
Neugebauer, W ;
Morley, P ;
Ross, V ;
Soska, M ;
Whitfield, JF ;
Willick, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) :1373-1380
[4]   Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone [J].
Chen, ZG ;
Xu, P ;
Barbier, JR ;
Willick, G ;
Ni, F .
BIOCHEMISTRY, 2000, 39 (42) :12766-12777
[5]  
Chimeh F, 2000, J BONE MINER RES, V15, pS232
[6]   MODIFICATIONS OF POSITION-12 IN PARATHYROID-HORMONE AND PARATHYROID-HORMONE RELATED PROTEIN - TOWARD THE DESIGN OF HIGHLY POTENT ANTAGONISTS [J].
CHOREV, M ;
GOLDMAN, ME ;
MCKEE, RL ;
ROUBINI, E ;
LEVY, JJ ;
GAY, CT ;
REAGAN, JE ;
FISHER, JE ;
CAPORALE, LH ;
GOLUB, EE ;
CAULFIELD, MP ;
NUTT, RF ;
ROSENBLATT, M .
BIOCHEMISTRY, 1990, 29 (06) :1580-1586
[7]   CYCLIC PARATHYROID-HORMONE RELATED PROTEIN ANTAGONISTS - LYSINE-13 TO ASPARTIC-ACID 17 [I TO (I + 4)] SIDE-CHAIN TO SIDE-CHAIN LACTAMIZATION [J].
CHOREV, M ;
ROUBINI, E ;
MCKEE, RL ;
GIBBONS, SW ;
GOLDMAN, ME ;
CAULFIELD, MP ;
ROSENBLATT, M .
BIOCHEMISTRY, 1991, 30 (24) :5968-5974
[8]   A HOT-SPOT OF BINDING-ENERGY IN A HORMONE-RECEPTOR INTERFACE [J].
CLACKSON, T ;
WELLS, JA .
SCIENCE, 1995, 267 (5196) :383-386
[9]   The bioactive conformation of human parathyroid hormone. Structural evidence for the extended helix postulate [J].
Condon, SM ;
Morize, I ;
Darnbrough, S ;
Burns, CJ ;
Miller, BE ;
Uhl, J ;
Burke, K ;
Jariwala, N ;
Locke, K ;
Krolikowski, PH ;
Kumar, NV ;
Labaudiniere, RF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (13) :3007-3014
[10]   Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence [J].
Cosman, F ;
Lindsay, R .
CALCIFIED TISSUE INTERNATIONAL, 1998, 62 (06) :475-480